摘要
肺间质纤维化(idiopathic pulmonaryfibrosis)是一种致病原因复杂、发病机制不清、缺乏有效治疗手段的致命性弥漫性肺间质疾病,其发病率及病死率逐年增高,确诊后平均存活期为2—4年,5年生存率仅为30%-50%。多种损伤因素均可单独或联合作用于肺脏,导致肺脏损伤与修复平衡失调,成纤维细胞和(或)细胞外基质沉积过度,最终形成肺纤维化。
出处
《中国基层医药》
CAS
2010年第9期1279-1280,共2页
Chinese Journal of Primary Medicine and Pharmacy
参考文献22
-
1Shi-Wen X,Denton CP,Dashwoud MR,et al.Fibmblast matrix gene expression and connective tissue remodeling:role of endothelin-1.J Invest Dermatol,2001,116(3):417-425.
-
2Selman M,Thannickal VJ,Pardo A,et al.Idiopathic pulmonary fibrosis:pathogenesis and therapeutic approaches.Drugs,2004,4(3):405-430.
-
3Yanagisawa M,Kurihara H,Kuri h ara S,et al.A novel potent vasoconstrictor peptide produced by vascular endothelial cells.Nature,1988,32 (6163):411-415.
-
4Rubany GM,Polokoff MA.Three mature(21-residue) endothelin isoforms(ET-1,ET-2,ET-3) are encode in human.PharmacolRev,1994,46(3):325-415.
-
5Tershita K,Kato S,Sata M,et al.Increased endiothelin-1 levels of BAL fluid in patients with pulmonary sarcoidosis.Am J Respirologr,2006,11 (2):145.
-
6Jain R,Shaul PW,Borok Z,et al.Endothelin-1 Induces Alveolar EMT Through ET-A-mediated Production of Transforming Growth Factor-β1.Am J Respir Cell Mol Biol,2007,37(1):38.
-
7Tsujino K,Hirota S,Endo M,et al.Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer.Int J Radiat Oncol Biol Phys,2003,55 (1):110.
-
8周华仕,张幸,洪长福.内皮素在肺纤维化发病机制中的作用[J].浙江省医学科学院学报,2004,15(1):35-39. 被引量:1
-
9Kyaw M,Yoshizumi M,Tsuchiya K,et al.Antioxidants inhibil endothelin-1(1-31)-induced proliferation of vascular smooth muscle cells via the inhibition of mitogen-activated protein(MAP) kinase and activator protein-1(AP-1) Biochem.Pharmacol,2002,(10):1521-1531.
-
10Jozsef L,Khreiss T,Fournier A,et al.Extracellular signal-regulated kinase plays an essential role in endothelin-1-induced homotypic adhesion of human neutrophil granulocytes.Br J Pharmacol,2002,135(5):1167-1174.
二级参考文献43
-
1韩文阳,王文杰.特发性肺纤维化治疗药物的最新研究进展[J].医学综述,2006,12(8):497-499. 被引量:7
-
2张雷杰,张本法.高压氧综合治疗系统性硬皮病10例[J].中华航海医学杂志,1996,3(4):243-243. 被引量:3
-
3Coker RK, Laurent GJ. Anti - cytokine approaches in pulmonary fibrosis:bring factors in focus [J]. Thorax, 1997 ;52:294 - 296.
-
4Coker RK, Laurent GJ. Pathogenesis of pulmonary fibrosis: implications for pharmacological intervention[A]. Walter EH, du Bois RM. Immunology and Management of Interstitial Lung Disease [ M ]. London: Chapman and Hall, 1995 : 19 - 36.
-
5Smith RE,Strieter RM,Phan SH,et al. TNF and IL -6 mediate MIP - 1 alpha expression in bleomycin - induced lung injury[J]. J Leukoc Biol, 1998 ;64:528 - 536.
-
6Szapiel SV, Elson NA,Fulmur JD, et al. Bleomycin - induced interstitial pulmonary disease in the nude,athymic mouse[J]. Am Rev Respir Dis, 1979 ; 120:893 - 897.
-
7Madtes DK, Elson AL, Hackman RL, et al. Transforming growth factor - alpha deficiency reduced pulmonary fibrosis in transgenic mice [ J ]. Am J Respir Cell Mol Biol, 1999 ;20:924 - 934.
-
8Sime P J, Marr RA, Gauldie D, et al. Tumor necrosis factor - alpha to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor - beta 1 and myofibrosis blasts[ J]. Am J Pathol, 1998 ; 153:825 - 832.
-
9Hoffman GS, Merkel PA, Brasington RD, et al. Anti - tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis [ J 1. Arthritis Rheum,2004 ; 50 : 2296 - 2304.
-
10Dpugla WW, Ryu JH,Schroeder DR. Idiopathic pulmonary fibrosis : im2 pact of oxygen and colchcines, prednisone, or no therapy on survival [J] .Am J Respir Cirt Care Med,2000;161:1172 - 1178.
共引文献40
-
1王媛,杨俊玲.血管紧张素Ⅱ在肺部疾病中的作用[J].中华哮喘杂志(电子版),2013,7(4):52-55. 被引量:3
-
2赵凯,屠文震.中西医结合治疗系统性硬皮病的思路与方法[J].中医杂志,2004,45(10):780-781. 被引量:6
-
3舒政,刘颖华,倪炯,孙凤,屠文震.系统性硬皮病肺纤维化HRCT表现与病程的关系[J].中国医学影像学杂志,2005,13(1):3-6. 被引量:2
-
4庞彩苓,徐志瑛.肺纤维化的中医药研究进展[J].浙江中医学院学报,2005,29(4):90-91. 被引量:8
-
5岑兆海.内皮素与肺纤维化关系的研究近况[J].中国医学文摘(内科学),2005,26(6):760-762.
-
6李明.结缔组织病诊疗进展[J].继续医学教育,2006,20(23):48-53. 被引量:2
-
7武慧,冯一中,顾振纶.肺间质纤维化的治疗现状[J].国际呼吸杂志,2006,26(8):620-624. 被引量:12
-
8许朝霞,丁明桥,陈瑞.概述肺纤维化的中医临床研究进展[J].中国民康医学,2006,18(19):882-884. 被引量:5
-
9吕晓东,庞立健.中医药治疗肺间质纤维化的进展[J].辽宁中医杂志,2006,33(12):1557-1559. 被引量:1
-
10钱先.补肺清瘀法促进硬皮病皮肤软化25例临床研究[J].江苏中医药,2007,39(3):20-22. 被引量:9
同被引文献9
-
1张战民,李立,赵建军.阿奇霉素对特发性肺间质纤维化干预作用的临床研究[J].中国综合临床,2005,21(12):1079-1081. 被引量:7
-
2Karla S, Utz JP, Ryu JH. Interferon gamma-lb therapy for advanced idiopathicpulrnonary fibrosis. Mayo Clinic Interstitial Lung Diseases Group. Mayo Clin Proc ,2003,78 (9) : 1082 -1087.
-
3Sharma S, Maycher B. Is HRCT the best way to diagnose idiopathic interstitial fibrosis. Curt Opin Pulmonary Meal,2006,12 ( 5 ) : 323-330.
-
4姜良铎,张晓梅,肖培新.特发性肺间质纤维化的病因病机探讨[J].中华中医药杂志,2008,23(11):984-986. 被引量:86
-
5王增祥,于金源,庞彩苓.克肺宁胶囊改善IPF患者生活质量的临床观察[J].中国实用医药,2009,4(7):141-142. 被引量:1
-
6柏媛,柴燕玲,张涛.特发性肺纤维化的治疗研究进展[J].临床肺科杂志,2009,14(11):1507-1508. 被引量:6
-
7崔社怀.特发性肺间质纤维化的回顾和展望[J].中华肺部疾病杂志(电子版),2010,3(1):4-5. 被引量:22
-
8薛江博.硫唑嘌呤联合阿奇霉素治疗特发性肺纤维化患者的临床研究[J].中国现代医生,2010,48(24):39-39. 被引量:2
-
9特发性肺(间质)纤维化诊断和治疗指南(草案)[J].中华结核和呼吸杂志,2002,25(7):387-389. 被引量:635
-
1顾国忠,赵继明.弥漫性肺间质疾病临床药物治疗进展[J].医学综述,1999,5(5):207-208. 被引量:1
-
2周慧会,张薇.A2BR与慢性阻塞性肺疾病及特发性肺间质纤维化的相关研究进展[J].中华临床医师杂志(电子版),2012,6(8).
-
3文明智,钟小宁.单核巨噬细胞在慢性阻塞性肺疾病中的作用[J].医学综述,2010,16(11):1622-1625.
-
4陈豪,江涛,周蜜.特发性肺纤维化治疗进展[J].临床肺科杂志,2015,20(9):1725-1727. 被引量:2
-
5刘小燕,李时悦.特发性肺纤维化的治疗进展[J].实用医学杂志,2008,24(9):1467-1469. 被引量:3
-
6褚衍彪,杨蕾,吴大玮.特发性间质性肺炎的诊断及治疗进展——弥漫性肺间质疾病诊断方法概述[J].山东医药,2005,45(4):63-64. 被引量:3
-
7肖洋,高洁.特发性肺纤维化的治疗进展[J].临床肺科杂志,2007,12(2):155-156. 被引量:6
-
8冯容.4个关键词:助你认识动脉硬化[J].大众医学,2012(8):31-31.
-
9岳红梅,余勤,张佳宾.肺泡灌洗液中转化生长因子β_1和胰岛素样生长因子1检测联合高分辨率CT对肺间质纤维化早期的诊断价值[J].临床荟萃,2005,20(8):448-450. 被引量:1
-
10徐兴祥,朱元珏.特发性肺纤维化治疗的研究进展[J].国外医学(呼吸系统分册),2004,24(3):146-149. 被引量:5